Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14463511 | 1.00 | ALDH1A1 (0.49) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5240143 | 0.98 | ALDH1A1 (0.47) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL16378120 | 0.80 | ALDH1A1 (0.47) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL12994836 | 0.80 | ALDH1A1 (0.47) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL21734377 | 0.78 | ALDH1A1 (0.36) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL23978582 | 0.77 | ALDH1A1 (0.45) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL13317748 | 0.77 | KMT2A (0.53) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL16925898 | 0.76 | ALDH1A1 (0.33) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL15872076 | 0.76 | KDM4E (0.31) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 | |
| SCHEMBL21895951 | 0.75 | CYP1A2 (0.47) | ALDH1A1GAAKDM4EMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758583-A2 | ARYLPIPERAZINE DERIVATIVES USEFUL AS ADRENERGIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2007-03-07 | — | — | EP | claimed |
| WO-2005118537-A2 | ARYLPIPERAZINE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-12-15 | — | — | WO | claimed |
| EP-3405010-B1 | MULTILAYER TRANSMISSION LINE PLATE | RESONAC CORP (JP) | 2024-06-26 | — | — | EP | disclosed |
| EP-3154997-B9 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2021-04-14 | — | — | EP | disclosed |
| EP-2637694-B1 | CONJUGATES OF AN IL-2 MOIETY AND A POLYMER | NEKTAR THERAPEUTICS (US) | 2021-04-07 | — | — | EP | disclosed |
| US-10957964-B2 | Multilayer transmission line plate | SHOWA DENKO MATERIALS CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| EP-3154997-B1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2020-02-19 | — | — | EP | disclosed |
| EP-2922575-B1 | TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF | HARVARD COLLEGE (US) | 2019-06-26 | — | — | EP | disclosed |
| US-10328141-B2 | Synthetic vaccines against Streptococcus pneumoniae type 1 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20190023899-A1 | MULTILAYER TRANSMISSION LINE PLATE | RESONAC CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-2482855-B1 | OLIGOMER-CALCIMIMETIC CONJUGATES AND RELATED COMPOUNDS | NEKTAR THERAPEUTICS (US) | 2017-12-27 | — | — | EP | disclosed |
| US-7767699-B2 | Therapeutic agents useful for treating pain | PURDUE PHARMA, L.P. (US) | 2010-08-03 | — | — | US | disclosed |
| US-7767699-B2 | Therapeutic agents useful for treating pain | PURDUE PHARMA, L.P. (US) | 2010-08-03 | — | — | US | disclosed |
| EP-1641775-B1 | 2-PYRIDINE ALKYNE DERIVATIVES USEFUL FOR TREATING PAIN | EURO CELTIQUE SA (LU) | 2009-02-18 | — | — | EP | disclosed |
| US-7470753-B2 | Silicone-modified antimicrobial polymer, antimicrobial agent and antimicrobial resin composition | CHISSO CORPORATION (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470753-B2 | Silicone-modified antimicrobial polymer, antimicrobial agent and antimicrobial resin composition | CHISSO CORPORATION (JP) | 2008-12-30 | — | — | US | disclosed |
| EP-1604647-B1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | CHISSO CORP (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-7256251-B2 | Methods of synthesis of polymers and copolymers from natural products | FOLIA INC. (US) | 2007-08-14 | — | — | US | disclosed |
| EP-1477512-B1 | Silicone-modified antimicrobial polymer, antimicrobial agent and antimicrobial resin composition | CHISSO CORP (JP) | 2007-07-25 | — | — | EP | disclosed |
| WO-2005007641-A1 | 2-PYRIDINE ALKYNE DERIVATIVES USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2005-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328141-B2 | Synthetic vaccines against Streptococcus pneumoniae type 1 | NEU1, ALG1, CSGALNACT1 | ALDH1A1 3507/4885GAA 625/4885KDM4E 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.